From the New York Times:
Drug Companies Seek to Mend Their Image
With drug prices skyrocketing, the pharmaceutical industry has long had plenty of critics. And in a measure of just how badly tarnished the industry's image has become, even some of its most prominent defenders are turning against it.

That could spell trouble, which is why the drug industry is about to begin a charm offensive to try to win back the nation's affection.

Roy Vagelos, the well-known former chairman of Merck & Company and one of the industry's most prominent boosters, now condemns drug makers for the "exorbitant" prices of new medicines and "galloping" annual increases of old ones. Government price controls, he predicts, are almost inevitable.